Table 1. Error percentages for 38 studies for the full ordinal scale (mRS 0.6), partially collapsed ordinal scale (mRS 0.3, 4–6) and dichotomization (mRS 0–1, 2–6; mRS 0–2, 3–6; mRS 0–3, 4–6; mRS 0–4, 5–6) and trichotomization (mRS 0–1, 2–4, 5–6; mRS 0–2, 3–4, 5–6) cut-points.
Study [Reference Number] | mRS 0.6 | mRS0.3, 4–6 | mRS0–1, 2–6 | mRS0–2, 3–6 | mRS0–3, 4–6 | mRS0–4, 5–6 | mRS0–1, 2–4, 5–6 | mRS0–2, 3–4, 5–6 |
ABESTT [36] | 25.64 | 23.37 | 9.41 | 8.62 | 6.24 | 2.27 | 11.68 | 10.89 |
ABESTTII [37] | 23.19 | 20.8 | 8.04 | 7.6 | 6.18 | 2.39 | 10.43 | 9.99 |
ABESTTIICo [37] | 27.26 | 24.8 | 9.29 | 9.77 | 6.99 | 2.46 | 11.75 | 12.23 |
ABESTTIIW [37] | 31.48 | 29.73 | 9.39 | 14.64 | 7.68 | 1.75 | 11.14 | 16.39 |
ARTIS [38] | 31.92 | 30.07 | 11.07 | 12.88 | 8.2 | 1.85 | 12.92 | 14.73 |
CAIST [39] | 26.7 | 25.22 | 11.71 | 8.73 | 5.84 | 1.48 | 13.19 | 10.21 |
CASTA-Cereb [40] | 30.4 | 27.44 | 9.39 | 11.49 | 8.24 | 2.96 | 12.35 | 14.45 |
Camerlingo [41] | 24.71 | 18.09 | 5.54 | 7.26 | 6.2 | 6.62 | 12.16 | 13.88 |
Cereb-rt-pa [42] | 23.45 | 21.94 | 9.73 | 7.3 | 6.07 | 1.51 | 11.24 | 8.81 |
DECIMAL [3] | 7.76 | 5.93 | 0 | 1.68 | 4.25 | 1.83 | 1.83 | 3.51 |
DESTINY [4] | 18.98 | 15.19 | 0 | 8.17 | 7.02 | 3.79 | 3.79 | 11.96 |
DP-b99 [43] | 25.84 | 20.41 | 4.87 | 7.75 | 9.07 | 5.43 | 10.3 | 13.18 |
DP-b99-MACSI [44] | 27.15 | 23.23 | 7.67 | 8.9 | 7.52 | 3.92 | 11.59 | 12.82 |
ECASSII [45] | 25.4 | 22.53 | 6.48 | 8.59 | 8.2 | 2.87 | 9.35 | 11.46 |
ECASSIII [46] | 22.09 | 19.37 | 8.93 | 6.56 | 4.96 | 2.72 | 11.65 | 9.28 |
EPITHET [47] | 27.83 | 23.9 | 7.85 | 9.1 | 8.16 | 3.93 | 11.78 | 13.03 |
EPO [48] | 26.13 | 20.76 | 7.08 | 7.1 | 7.42 | 5.37 | 12.45 | 12.47 |
Edaravone [49] | 29.37 | 26.69 | 13.2 | 9.22 | 6.16 | 2.68 | 15.88 | 11.9 |
Enlimomab [50] | 24.61 | 21.55 | 7.02 | 8.75 | 6.91 | 3.06 | 10.08 | 11.81 |
FIST [51] | 24.14 | 20.39 | 5.15 | 9.33 | 7.03 | 3.75 | 8.9 | 13.08 |
GAIN [52] | 26.19 | 21.55 | 5.61 | 8.02 | 8.93 | 4.64 | 10.25 | 12.66 |
HAMLET [5] | 16.99 | 15.62 | 1.79 | 7.43 | 7.18 | 1.37 | 3.16 | 8.8 |
ICTUS [53] | 25.14 | 21.24 | 4.85 | 8.53 | 8.93 | 3.9 | 8.75 | 12.43 |
IMS-III [54] | 25.54 | 22.49 | 7.35 | 9.26 | 6.9 | 3.05 | 10.4 | 12.31 |
INSULINFARCT [55] | 29.59 | 27.27 | 8.66 | 11.46 | 9.11 | 2.32 | 10.98 | 13.78 |
IST-3 [22] | 23.05 | 18.38 | 6.31 | 7.56 | 5.52 | 4.67 | 10.98 | 12.23 |
MELT [56] | 32.31 | 25.52 | 7.45 | 10.83 | 8.58 | 6.79 | 14.24 | 17.62 |
MR-RESCUE-Pen [57] | 32.33 | 26.17 | 4.45 | 11.1 | 11.22 | 6.16 | 10.61 | 17.26 |
MR-RES-Non-Pen [57] | 25.97 | 17.26 | 1.89 | 6.44 | 9.28 | 8.71 | 10.6 | 15.15 |
Minocycline [58] | 44.37 | 43.99 | 6.99 | 24.82 | 14.12 | 0.38 | 7.37 | 25.2 |
NEST-1 [59] | 27.22 | 22.53 | 7.2 | 8.53 | 7.43 | 4.69 | 11.89 | 13.22 |
NEST-2 [60] | 29.17 | 25.13 | 5.69 | 10.94 | 9.84 | 4.04 | 9.73 | 14.98 |
NINDS [61] | 23.96 | 20.57 | 6.19 | 7.88 | 7.45 | 3.39 | 9.58 | 11.27 |
PROACTII [62] | 24.09 | 20.31 | 2.85 | 8.89 | 9.16 | 3.78 | 6.63 | 12.67 |
SAINTI [20] | 25.08 | 21.71 | 7.6 | 7.13 | 7.96 | 3.37 | 10.97 | 10.5 |
SAINTII [21] | 26.24 | 22.5 | 7.3 | 9.02 | 7.26 | 3.74 | 11.04 | 12.76 |
Synthesis [63] | 25.16 | 22.32 | 5.02 | 7.32 | 10.25 | 2.84 | 7.86 | 10.16 |
Synthesis Exp [64] | 26.51 | 22.88 | 7.12 | 8.18 | 8.35 | 3.63 | 10.75 | 11.81 |